FLT3 and acute myeloid leukemia: Concerning previous treatment lines for AML, 22 (59%) patients had received intensive chemotherapy +/- FLT3 inhibitors, 5 (14%) had received only HMAs and 10 (27%) had received both intensive chemotherapy and HMAs.